Scott A. Armstrong

Person

Wayland, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
DOT1L degraders and uses thereof
- Patent number 12,331,069
- Issue date Jun 17, 2025
- Dana-Farber Cancer Institute, Inc.
- Scott Armstrong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DOT1L degraders and uses thereof
- Patent number 11,634,450
- Issue date Apr 25, 2023
- Dana-Farber Cancer Institute, Inc.
- Jun Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the detection and treatment of leukemias that are respo...
- Patent number 11,603,570
- Issue date Mar 14, 2023
- Memorial Sloan Kettering Cancer Center
- Scott A. Armstrong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibition of KMT2D for the treatment of cancer
- Patent number 11,248,229
- Issue date Feb 15, 2022
- Memorial Sloan Kettering Cancer Center
- Jose Baselga
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeting chromatin regulators inhibits leukemogenic gene expressio...
- Patent number 10,869,868
- Issue date Dec 22, 2020
- Memorial Sloan Kettering Cancer Center
- Scott A. Armstrong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the detection and treatment of leukemias that are respo...
- Patent number 10,407,732
- Issue date Sep 10, 2019
- Memorial Sloan Kettering Cancer Center
- Scott A. Armstrong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating mixed lineage leukemia gene-rearranged acute lym...
- Patent number 9,700,565
- Issue date Jul 11, 2017
- Dana-Farber Cancer Institute, Inc.
- James Douglas Griffin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MLL translocations specify a distinct gene expression profile, dist...
- Patent number 7,011,947
- Issue date Mar 14, 2006
- Whitehead Institute for Biomedical Research
- Todd R. Golub
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC TARGETING OF GASTROINTESTINAL STROMAL TUMOR (GIST) BY D...
- Publication number 20250041299
- Publication date Feb 6, 2025
- Dana-Farber Cancer Institute, Inc.
- Scott A. ARMSTRONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING DOT1L AND SMARCA4/2 FOR THE TREATMENT OF MLLR LEUKEMIA
- Publication number 20240335438
- Publication date Oct 10, 2024
- Dana-Farber Cancer Institute, Inc.
- Jun Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS FOR PROTEIN DEGRADATION
- Publication number 20220389023
- Publication date Dec 8, 2022
- Dana-Farber Cancer Institute, Inc.
- Jun Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF KMT2D FOR THE TREATMENT OF CANCER
- Publication number 20220307031
- Publication date Sep 29, 2022
- Memorial Sloan-Kettering Cancer Center
- Jose Baselga
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOT1L DEGRADERS AND USES THEREOF
- Publication number 20220048942
- Publication date Feb 17, 2022
- Dana-Farber Cancer Institute, Inc.
- Scott Armstrong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOT1L DEGRADERS AND USES THEREOF
- Publication number 20210130386
- Publication date May 6, 2021
- Dana-Farber Cancer Institute, Inc.
- Jun Qi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR THE DETECTION AND TREATMENT OF LEUKEMIAS THAT ARE RESPO...
- Publication number 20200239963
- Publication date Jul 30, 2020
- Memorial Sloan-Kettering Cancer Center
- Scott A. ARMSTRONG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSIO...
- Publication number 20190307750
- Publication date Oct 10, 2019
- Memorial Sloan-Kettering Cancer Center
- Scott A. ARMSTRONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF KMT2D FOR THE TREATMENT OF CANCER
- Publication number 20190270997
- Publication date Sep 5, 2019
- Memorial Sloan-Kettering Cancer Center
- Jose Baselga
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lym...
- Publication number 20170209458
- Publication date Jul 27, 2017
- DANA-FARBER CANCER INSTITUTE INC.
- James Douglas Griffin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE DETECTION AND TREATMENT OF LEUKEMIAS THAT ARE RESPO...
- Publication number 20160298195
- Publication date Oct 13, 2016
- Memorial Sloan-Kettering Cancer Center
- Scott A. ARMSTRONG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL SIGNATURE SELF RENEWAL GENE EXPRESSION PROGRAMS
- Publication number 20090324618
- Publication date Dec 31, 2009
- Scott A. Armstrong
- G01 - MEASURING TESTING
Information Patent Application
MLL translocations specify a distinct gene expression profile, dist...
- Publication number 20060057630
- Publication date Mar 16, 2006
- Todd R. Golub
- G01 - MEASURING TESTING
Information Patent Application
MLL translocations specify a distinct gene expression profile, dist...
- Publication number 20060024734
- Publication date Feb 2, 2006
- Todd R. Golub
- G01 - MEASURING TESTING
Information Patent Application
MLL translocations specify a distinct gene expression profile, dist...
- Publication number 20030134300
- Publication date Jul 17, 2003
- Whitehead Institute for Biomedical Research
- Todd R. Golub
- G01 - MEASURING TESTING

Scott A. Armstrong

Person

Patents Grantslast 30 patents

DOT1L degraders and uses thereof

DOT1L degraders and uses thereof

Methods for the detection and treatment of leukemias that are respo...

Inhibition of KMT2D for the treatment of cancer

Targeting chromatin regulators inhibits leukemogenic gene expressio...

Methods for the detection and treatment of leukemias that are respo...

Method of treating mixed lineage leukemia gene-rearranged acute lym...

MLL translocations specify a distinct gene expression profile, dist...

Patents Applicationslast 30 patents

THERAPEUTIC TARGETING OF GASTROINTESTINAL STROMAL TUMOR (GIST) BY D...

TARGETING DOT1L AND SMARCA4/2 FOR THE TREATMENT OF MLLR LEUKEMIA

COMPOUNDS, COMPOSITIONS, AND METHODS FOR PROTEIN DEGRADATION

INHIBITION OF KMT2D FOR THE TREATMENT OF CANCER

DOT1L DEGRADERS AND USES THEREOF

DOT1L DEGRADERS AND USES THEREOF

METHODS FOR THE DETECTION AND TREATMENT OF LEUKEMIAS THAT ARE RESPO...

TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSIO...

INHIBITION OF KMT2D FOR THE TREATMENT OF CANCER

Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lym...

METHODS FOR THE DETECTION AND TREATMENT OF LEUKEMIAS THAT ARE RESPO...

NOVEL SIGNATURE SELF RENEWAL GENE EXPRESSION PROGRAMS

MLL translocations specify a distinct gene expression profile, dist...

MLL translocations specify a distinct gene expression profile, dist...

MLL translocations specify a distinct gene expression profile, dist...